Fabricating carbon quantum dots of graphitic carbon nitride vis ultrasonic exfoliation for highly efficient H2O2 production.

A promising and sustainable approach for producing hydrogen peroxide is the two-electron oxygen reduction reaction (2e- ORR), which uses very stable graphitic carbon nitride (g-C3N4). However, the catalytic performance of pristine g-C3N4 is still far from satisfactory. Here, we demonstrate for the first time the controlled fabrication of carbon quantum dots (CQDs)-modified graphitic carbon nitride carbon (g-C3N4/CQDs-X) by ultrasonic stripping for efficient 2e- ORR electrocatalysis. HRTEM, UV-vis, EPR and EIS analyses are in good consistent which prove the in-situ generation of CQDs. The effect of sonication time on the physical properties and ORR activity of g-C3N4 is discussed for the first time. The g-C3N4/CQDs-12 catalyst shows a selectivity of up to 95% at a potential of 0.35 V vs. RHE, which is much higher than that of the original g-C3N4 catalyst (88%). Additionally, the H2O2 yield is up to 1466.6 mmol g-1 in 12 h, which is twice as high as the original g-C3N4 catalyst. It is discovered that the addition of CQDs through ultrasonic improves the g-C3N4 catalyst's electrical conductivity and electron transfer capability in addition to its high specific surface area and distinctive porous structure, speeding up the reaction rate. This research offers a green method for enhancing g-C3N4 activity.

Small Molecular Mimetics of Antimicrobial Peptides as a Promising Therapy To Combat Bacterial Resistance.

Clinically, antibiotics are widely used to treat infectious diseases; however, excessive drug abuse and overuse exacerbate the prevalence of drug-resistant bacterial pathogens, making the development of novel antibiotics extremely difficult. Antimicrobial peptide (AMP) is one of the most promising candidates for overcoming bacterial resistance owing to its unique structure and mechanism of action. This study examines the development of small molecular mimetics of AMPs over the past two decades. These mimetics can selectively disrupt membranes, which are the characteristic antibacterial mechanism of AMPs. In addition, the advantages and disadvantages of small AMP mimetics are discussed. The small molecular mimetics of AMPs are anticipated to garner interest and investment in discovering new antibiotics. This Perspective will assist in revitalizing the golden age of antibiotics in the current era of combating bacterial resistance.